112 related articles for article (PubMed ID: 3219975)
1. [Amplification and rearrangement of proto-oncogene c-abl in human leukemia cells].
Jin XM; Miao J; Xu Y; Deng GR
Zhonghua Zhong Liu Za Zhi; 1988 May; 10(3):167-70. PubMed ID: 3219975
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism of the human c-abl gene: relation to incidence and course of chronic myelogenous leukemia.
Daniel L; Ahmed CM; Bloodgood RS; Kidd JR; Castiglione CM; Duttagupta S; Lebowitz P
Oncogene; 1987 May; 1(2):193-200. PubMed ID: 2894000
[TBL] [Abstract][Full Text] [Related]
3. Further evidence of the involvement of the c-abl oncogene in chronic myelogenous leukemia and acute lymphocytic leukemia.
Szabo P; Macera MJ; Verma RS
Mol Biol Med; 1988 Dec; 5(3):139-44. PubMed ID: 3072467
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of dual color-dual fusion translocation fluorescence in situ hybridization in the detection of bcr/abl fusion gene.
Wu B; Zhou S; Song L; Liu X
Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):364-6. PubMed ID: 12408765
[TBL] [Abstract][Full Text] [Related]
5. [The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia].
González FA; Villegas A; Ferro MT; San Román C; Sáez I; López M; del Potro E; Alvarez A; Martínez R; Díaz Madiavilla J
Med Clin (Barc); 1993 Oct; 101(14):521-4. PubMed ID: 8231395
[TBL] [Abstract][Full Text] [Related]
6. Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia.
Guo JQ; Hirsch-Ginsberg CF; Xian YM; Stass SA; Champlin RE; Giralt SA; McCredie KB; Campbell ML; Arlinghaus RB
Hematol Pathol; 1993; 7(2):91-106. PubMed ID: 8340287
[TBL] [Abstract][Full Text] [Related]
7. Bcr-Abl has a greater intrinsic capacity than v-Abl to induce the neoplastic expansion of myeloid cells.
Gross AW; Ren R
Oncogene; 2000 Dec; 19(54):6286-96. PubMed ID: 11175343
[TBL] [Abstract][Full Text] [Related]
8. Breakpoint cluster region, immunoglobulin, and T-cell receptor gene rearrangement analysis in juvenile chronic myelogenous leukemia.
Farhi DC; Luckey CN; Siddiqui AM
Mod Pathol; 1995 May; 8(4):389-93. PubMed ID: 7567936
[TBL] [Abstract][Full Text] [Related]
9. Analysis of A-MuLV transformed fibroblast lines for amplification of the c-myc, p53 and c-fos nuclear proto-oncogenes.
Colledge WH; Gebhardt A; Edge MD; Bell JC
Oncogene; 1989 Jun; 4(6):753-7. PubMed ID: 2543944
[TBL] [Abstract][Full Text] [Related]
10. ABL oncogenes and phosphoinositide 3-kinase: mechanism of activation and downstream effectors.
Kharas MG; Fruman DA
Cancer Res; 2005 Mar; 65(6):2047-53. PubMed ID: 15781610
[TBL] [Abstract][Full Text] [Related]
11. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional activation of human LIM-HOX gene, hLH-2, in chronic myelogenous leukemia is due to a cis-acting effect of Bcr-Abl.
Wu HK; Minden MD
Biochem Biophys Res Commun; 1997 Apr; 233(3):806-12. PubMed ID: 9168938
[TBL] [Abstract][Full Text] [Related]
13. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.
Kögler G; Hernandez A; Heyll A; Wolf HH; Wernet P
Cancer Detect Prev; 1996; 20(6):601-9. PubMed ID: 8939346
[TBL] [Abstract][Full Text] [Related]
14. [Oncogenes in human leukemia].
Takaku F
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):617-23. PubMed ID: 2650633
[TBL] [Abstract][Full Text] [Related]
15. [Detection of BCR-ABL gene sequences using RT-PCR in patients with leukemia in the IX region. Chile].
Artigas CG; Melo A; Roa JC; Páez E; Vittini C; Arriagada M; González L; Pflaumer E; Roa I
Rev Med Chil; 2002 Jun; 130(6):623-30. PubMed ID: 12194684
[TBL] [Abstract][Full Text] [Related]
16. Ribozyme-mediated inhibition of a Philadelphia chromosome-positive acute lymphoblastic leukemia cell line expressing the p190 bcr-abl oncogene.
Snyder DS; Wu Y; McMahon R; Yu L; Rossi JJ; Forman SJ
Biol Blood Marrow Transplant; 1997 Oct; 3(4):179-86. PubMed ID: 9360779
[TBL] [Abstract][Full Text] [Related]
17. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
Okabe M
Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066
[TBL] [Abstract][Full Text] [Related]
18. The incidence of submicroscopic deletions in reciprocal translocations is similar in acute myeloid leukemia, BCR-ABL positive acute lymphoblastic leukemia, and chronic myeloid leukemia.
Bacher U; Schnittger S; Kern W; Hiddemann W; Haferlach T; Schoch C
Haematologica; 2005 Apr; 90(4):558-9. PubMed ID: 15820957
[TBL] [Abstract][Full Text] [Related]
19. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients.
Klobusická M; Kusenda J; Babusíková O
Neoplasma; 2003; 50(6):408-15. PubMed ID: 14689061
[TBL] [Abstract][Full Text] [Related]
20. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
